Abstract: Provided herein are dental adhesives that contain a dental adhesive material and a multifunctional magnetic platform. The multifunctional magnetic platform has a core-shell structure. The core includes magnetic microparticles and an antibiotic with the core capped by an antibacterial silane coating. Also provided are methods utilizing the dental adhesives for increasing longevity of a dental restoration and for restoring a tooth in a subject.
Type:
Application
Filed:
March 1, 2024
Publication date:
September 5, 2024
Applicant:
University of Maryland, Baltimore
Inventors:
Mary Anne S. Melo, Michael D. Weir, Lamia Sami Mokeem
Abstract: Provided herein are fusion proteins engineered from a dysferlin C2 domain sequence linked to a sequence of a homologous fusion partner, vector constructs with cDNA encoding the fusion proteins and viral vectors with the vector constructs and a promoter to control expression thereof. Also provided are methods for treating a dysferlinopathy in a subject in need thereof, for suppressing pathogenic Ca2+ signaling in a dysferlinopathic muscle and for targeting proteins to triad junctions in skeletal muscles all utilizing at least the fusion proteins.
Type:
Application
Filed:
June 7, 2022
Publication date:
September 5, 2024
Applicant:
University of Maryland, Baltimore
Inventors:
Robert J. Bloch, Joaquin Muriel, Valeriy Lukyanenko, Noah Weisleder
Abstract: Novel, antibody-based binding agents derived from camelid VHH and human immunoglobulins are described. These binding agents recognize and bind with specificity to Clostridium difficile toxin A and/or toxin B and in some cases exhibit toxin neutralizing activity. These binding agents can be used to treat or prevent primary and recurrent CDI. The binding agents include humanized VHH peptide monomers, linked groups of humanized VHH peptide monomers, humanized VHH peptide monomers joined to antibody Fc domains, and humanized VHH peptide monomers joined to IgG antibodies.
Type:
Grant
Filed:
June 3, 2020
Date of Patent:
September 3, 2024
Assignees:
FZATA, INC., UNIVERSITY OF MARYLAND, BALTIMORE
Abstract: Embodiments of the disclosure provide for unique lipooligosaccharide/lipid A-based mimetics for use as adjuvants. Methods of generating lipooligosaccharide/lipid A-based mimetics are provided that utilize recombinantly engineered bacteria to produce the mimetics, including, for example, addition of one or more particular enzymes such as acyltransferases, deacylases, phosphatases, or glycosyltransferases.
Type:
Grant
Filed:
August 23, 2021
Date of Patent:
September 3, 2024
Assignees:
University of Maryland, Baltimore, University of Washington
Inventors:
Robert K. Ernst, Mark Pelletier, Adeline Hajjar
Abstract: Methods for preventing neural tube defects in embryos of diabetic females via administration of Survivin-containing exosomes derived from Flk-1+ mesoderm progenitor cells are reported.
Abstract: A prosthetic stem is configured to reduce the perioperative and intraoperative risk of catastrophic medical complications and death that may be caused by BCIS. The prosthetic stem includes one or more internal channels that are configured to self-regulate intramedullary pressure within a prepared bone channel as the stem is inserted into the channel, thus reducing the likelihood of BCIS without sacrificing biomechanics and maintaining a reliable and repeatable implantation process. The stem includes a head and a body, wherein the head is configured to serve as a joint replacement and the body is configured for insertion into the prepared bone channel of a patient. One or more internal channels in the stem are configured to control the pressure within the prepared bone channel during insertion of the stem into the channel, particularly by forming a path through which excess cement may flow as the stem proceeds into the prepared bone channel.
Abstract: A method and system detects a hypoxic condition during an obstruction of an airway of a subject to detect and treat obstructive sleep apnea (OSA) in the subject. The method and system includes an organ stimulating transducer configured for placement in a vicinity of an organ of the subject to stimulate the organ and remove the obstruction when OSA is detected.
Type:
Grant
Filed:
January 24, 2019
Date of Patent:
August 27, 2024
Assignees:
University Of Maryland, Baltimore, Sonosa Medical, Inc.
Inventors:
Amal Isaiah, Jeffrey S. Wolf, Stephen Restaino
Abstract: Embodiments of the disclosure concern compositions and methods of use related to particular c-kit+ mesenchymal cells, including cardiac stem cells, obtained from a pediatric or neonatal individual. In specific embodiments, the cells, or conditioned medium or partial or total secretomes thereof, are provided in an effective amount to an individual in need thereof.
Abstract: A method of using the transverse relaxation rate (R2) of solvent NMR signal to noninvasively assess if an alum-containing product, such as a vaccine, has been acceptably resuspended for use following transport and/or storage. This technique allows for the manufacturer and/or distributor and/or end user to monitor for unexpected stressors associated with transport and/or storage including, but not limited to, temperature fluctuations, pH changes, vigorous shaking during transportation, exposure to sunlight, and freezing.
Type:
Grant
Filed:
February 16, 2023
Date of Patent:
August 13, 2024
Assignees:
UNIVERSITY OF MARYLAND, BALTIMORE, ACCESS TO ADVANCED HEALTH INSTITUTE
Inventors:
Yihua (Bruce) Yu, Marc Taraban, Christopher Fox
Abstract: An energy-efficient method of controlling the composite microstructure and resulting thermoelectric (TE) properties of TE composite films. The TE composite films, which include a small amount of naturally occurring chitosan binder that is sufficient to hold TE particles together, are modified by applying uniaxial mechanical pressure at low temperatures for a short duration. The TE composite films have high electrical conductivity and low thermal conductivity, making them ideal for use into high-performance energy harvesting thermoelectric devices.
Type:
Grant
Filed:
March 29, 2022
Date of Patent:
July 16, 2024
Assignee:
UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
Abstract: The present invention discloses a self-sealing cannula and methods of its use. The self-sealing cannula can be minimally invasively placed into the heart for drawing and/or returning blood with a self-sealing function at the interface of the blood access site. The disclosed cannula can be implemented as a single lumen cannula or a double lumen cannula, which can be used with ventricular assist devices for heart support or pump-oxygenators for ECMO and respiratory support. Through a self-sealing mechanism fixed on the ventricular wall or atrial wall, a cannula body is attached to the self-sealing fixture and blood is drawn into the lumen via an external pump and returned to the circulation system through a separate cannula. In the case of the double lumen cannula embodiment, the blood will be drawn into the drainage lumen of the double lumen cannula and returned through an infusion lumen at the desired location.
Type:
Grant
Filed:
June 3, 2020
Date of Patent:
June 11, 2024
Assignee:
University of Maryland, Baltimore
Inventors:
Zhongjun Wu, Bartley P. Griffith, Keshava Rajagopal
Abstract: Disclosed is a system and method for the placement of elongate medical members within a patient's body using coaptive ultrasound that combines magnetic guidance with ultrasound visualization of the medical member in the patient's body. A coaptive ultrasound probe adaptor magnetically attracts an elongate medical member within the patient with sufficient force so as to allow the operator to manually guide the member to its intended location. The adaptor mates with an ultrasound probe to provide the medical operator ultrasound feedback of the position of the member, thus allowing internal placement without the need for more specialized medical equipment.
Abstract: The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleosides analogs. Specifically, the present invention provides for the design and synthesis of acyclic fleximer nucleoside analogues having increased flexibility and ability to alter their conformation structures to provide increased antiviral activity potential with the result of inhibiting flaviviruses, filoviruses and/or coronaviruses.
Type:
Grant
Filed:
January 6, 2022
Date of Patent:
May 14, 2024
Assignee:
UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
Abstract: A method of using the transverse relaxation time (T2) of solvent NMR signal to detect filling errors of an alum-containing product in real-time and in-line during manufacturing, for example during a fill-finish unit operation. This method can be used for quality control in vaccine manufacturing to ensure the delivery of the correct concentration of alum-containing product to the product container such as a vial or pre-filled syringe.
Abstract: The invention provides compositions comprising multipotent progenitor cells isolated from tonsillar tissue and differentiated cells derived therefrom and methods for using the cells for the treatment of diseases or disorders.
Abstract: A method of using the relaxation rate (R1 and/or R2) of solvent NMR signal to noninvasively assess whether viral capsids in a capsid preparation are full or empty, and the percentage of full capsids if the vial contains a mixture of full and empty capsids. The method can simply, rapidly, and non-invasively prove the safety and potency of the capsid preparation and thus whether the capsid preparation can be approved for clinical use, without requiring any sample preparation or reagent addition.
Abstract: Described herein are devices and methods for mitral valve repair. The devices and methods implant a plurality of distal anchors at an annulus of the mitral valve (e.g., the posterior annulus) and tension artificial chordae to pull the portion of the annulus toward an opposite edge and inward into the ventricle. This can effectively reduce the size of the orifice and increase coaptation. The delivery devices can be configured to be actuated to form a distal anchor made of a pre-formed knot. The delivery devices deliver the pre-formed knot in an elongate configuration. Actuation of the delivery device causes the pre-formed knot to transition from the elongate configuration to the deployed configuration by approximating opposite ends of a suture coupled to a coiled configuration to form one or more loops. After formation of the knot, the delivery device can be withdrawn.
Type:
Grant
Filed:
September 4, 2020
Date of Patent:
April 2, 2024
Assignees:
University of Maryland, Baltimore, Harpoon Medical, Inc.
Inventors:
Michael Nicholas D'ambra, Felino V. Cortez, Jr., James S. Gammie, Peter Wilson, Stephen Epstein, Stephen Cournane, Julie Marie Etheridge, Peter Boyd
Abstract: Techniques are presented for optimizing a treatment plan for charged particle therapy. The method includes obtaining medical image data voxels inside a subject in a reference frame of a radiation source that emits a beam of charged particles at multiple tracks with a controlled emitted energy at each track. Hydrogen density (HD) is determined based on the medical image data. Stopping power ratio (SPR) along a first beam having a first track and first emitted energy is calculated based on HD. A range to a Bragg peak is calculated along the first beam based on the SPR and the first emitted energy. The first beam track or the first emitted energy, or both, is modified based at least in part on the beam range to determine a second track and second emitted energy. Output data that indicates the second track and second emitted energy are sent.
Type:
Grant
Filed:
March 11, 2019
Date of Patent:
March 19, 2024
Assignee:
University Of Maryland, Baltimore
Inventors:
Byong Yong Yi, Ulrich Langner, Sina Mossahebi, Chaitanya Kalavagunta
Abstract: A one-dimensional (1D) and two-dimensional (2D) scan scheme for a tracking continuously scanning laser Doppler vibrometer (CSLDV) system to scan the whole surface of a rotating structure excited by a random force. A tracking CSLDV system tracks a rotating structure and sweep its laser spot on its surface. The measured response of the structure using the scan scheme of the tracking CSLDV system is considered as the response of the whole surface of the structure subject to random excitation. The measured response can be processed by operational modal analysis (OMA) methods (e.g., an improved lifting method, an improved demodulation method, an improved 2D demodulation method). Damped natural frequencies of the rotating structure are estimated from the fast Fourier transform of the measured response. Undamped full-field mode shapes are estimated by multiplying the measured response using sinusoids whose frequencies are estimated damped natural frequencies.
Type:
Grant
Filed:
October 21, 2022
Date of Patent:
March 5, 2024
Assignee:
UNIVERSITY OF MARYLAND, BALTIMORE COUNTY